Abstract | OBJECTIVE: METHODS: In a randomised, double-blind manner, 120 patients, 60 younger (aged 20-40 years) and 60 older (aged 60-80 years) adults, received placebo (saline) or metoclopramide intravenously at two different doses (2.5mg and 5 mg) [younger group n = 20 each, older group n = 20 each], with venous occlusion for 1 minute, followed by administration of propofol 0.5 mg/kg into a dorsal hand vein. A blinded researcher asked the patient to assess the pain according to a pain score (0 = none, 1 = mild, 2 = moderate, 3 = severe) during injection of propofol. RESULTS: For younger patients, the incidence of propofol-induced pain was 30% in patients receiving metoclopramide 5mg (both p < 0.05), 70% in those receiving metoclopramide 2.5mg and 80% in those receiving placebo. The median pain score was lower in patients receiving metoclopramide 5mg (0) than in those receiving placebo (1.5) [p < 0.05]. For older patients, 15 patients (75%) complained of pain in the placebo group, compared with six (30%) in the metoclopramide 5mg group (p < 0.01) and seven (35%) in the metoclopramide 2.5mg group (p < 0.05). The median pain score was lower in patients receiving metoclopramide 5mg (0) [p < 0.01] or metoclopramide 2.5mg (0) [p < 0.05] than in those receiving placebo (1). CONCLUSION: This study showed that older patients require less metoclopramide, with venous occlusion for 1 minute, to reduce pain on injection of propofol than do younger patients.
|
Authors | Yoshitaka Fujii, Yuka Shiga |
Journal | Clinical drug investigation
(Clin Drug Investig)
Vol. 26
Issue 11
Pg. 639-44
( 2006)
ISSN: 1173-2563 [Print] New Zealand |
PMID | 17163298
(Publication Type: Journal Article, Randomized Controlled Trial, Retracted Publication)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Aging
(physiology)
- Double-Blind Method
- Female
- Humans
- Injections
(adverse effects)
- Male
- Metoclopramide
(therapeutic use)
- Middle Aged
- Pain
(prevention & control)
- Propofol
(administration & dosage)
|